BWAY Brainsway

BrainsWay’s Deep TMS Takes Center Stage at Clinical TMS Society Annual Poster Session

BrainsWay’s Deep TMS Takes Center Stage at Clinical TMS Society Annual Poster Session
EN
06/10/2020

Underlying

BWAYBrainsway

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Brainsway

 PRESS RELEASE
Free
BWAY BRAINSWAY

BrainsWay to Report Fourth Quarter and Full Year 2025 Financial Result...

BrainsWay to Report Fourth Quarter and Full Year 2025 Financial Results on March 11, 2026 BURLINGTON, Mass. and JERUSALEM, Feb. 25, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation technologies, today announced that it will report its fourth quarter and full year 2025 financial results, as well as operational highlights, before the open of the U.S. financial markets on Wednesday, March 11, 2026. The Company will host a conference call and webcast at 8:30 AM Eastern Time to discuss the res...

February 25, 2026 1 EN
 PRESS RELEASE
Free
BWAY BRAINSWAY

BrainsWay to Participate in the Citi 2026 Unplugged MedTech and Life S...

BrainsWay to Participate in the Citi 2026 Unplugged MedTech and Life Sciences Access Day BURLINGTON, Mass. and JERUSALEM, Feb. 23, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive brain stimulation technologies, today announced that management will participate in one-on-one meetings at the Citi 2026 Unplugged MedTech and Life Sciences Access Day on Thursday, February 26, 2026, in New York, NY. Please contact your Citi representative to request a meeting at the conference. About BrainsWayBrainsWay is a g...

February 23, 2026 1 EN
 PRESS RELEASE
Free
BWAY BRAINSWAY

BrainsWay Announces New Minority-Stake Investment in Canadian Provider...

BrainsWay Announces New Minority-Stake Investment in Canadian Provider, BrainStim Health Inc. BrainsWay continues to actively evaluate similar investments in leading North American mental health providers to raise awareness and expand access to transformative care BURLINGTON, Mass. and JERUSALEM, Feb. 19, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced it has entered into a strategic equity financing agreement with BrainStim Health...

February 19, 2026 1 EN
 PRESS RELEASE
Free
BWAY BRAINSWAY

BrainsWay Reports Cigna’s Evernorth Behavioral Health to Eliminate Pri...

BrainsWay Reports Cigna’s Evernorth Behavioral Health to Eliminate Prior Authorization Requirements for TMS Coverage, Accelerating Access to Care BURLINGTON, Mass. and JERUSALEM, Feb. 18, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive brain stimulation technologies, today commented on the recent  issued by Evernorth® Behavioral Health, Inc., a division of the Cigna Group, which serves over 18 million covered lives across 12 states, that it will no longer require prior authorization for transcranial magn...

February 18, 2026 1 EN
 PRESS RELEASE
Free
BWAY BRAINSWAY

BrainsWay Announces Change in ADS-to-Ordinary Share Ratio

BrainsWay Announces Change in ADS-to-Ordinary Share Ratio Change in ADS ratio aimed at simplifying comparisons to ordinary shares traded on the Tel Aviv Stock Exchange, while boosting liquidity and access for U.S. investors BURLINGTON, Mass. and JERUSALEM, Feb. 17, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive brain stimulation technologies, today announced that its Board of Directors approved a plan to change to the ratio of its American Depositary Shares (ADSs) listed on the Nasdaq Capital Market (...

February 17, 2026 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch